Developing Imaging And plasMa biOmarkers iN Describing Heart Failure With Preserved Ejection Fraction (DIAMONDHFpEF)

Exclusion Criteria

• •Myocardial infarction within the preceding 6 months
• •Suspected or confirmed cardiomyopathy (e.g. hypertrophic, infiltrative)
• •Suspected or confirmed constrictive pericarditis
• •Significant native valve disease (≥ moderate severity)
• •Known Significant lung disease (documented or FEV1\< 30% or FVC \< 50%)
• •Non-cardiovascular co-morbidity likely to cause death within 6 months (e.g. malignancy)
• •Significant renal failure (estimated GFR \< 30 ml/min/m2)
• •Patient inability to provide informed consent (e.g. dementia)